VC-backed Bolt Biotherapeutics debuts IPO

Bolt Biotherapeutics Inc has gone public after pricing its 11.5 million shares at $20 per share.

5 February 2021•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare IPO Briefs